Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group57

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group19

Views

Views
June 20254
July 202510
August 20252
September 20251
October 20250
November 20252
December 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Brazil5
Germany2
Argentina2
Bolivia1
Canada1
United Kingdom1
Paraguay1
 

Top cities views

Views
Nuremberg2
São Paulo2
Dallas2
Brampton1
Ciudad del Este1
Goiânia1
Guapimirim1
La Paz1
Moreno1
São Luís1